National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

cBR96-doxorubicin immunoconjugate (... DOK-soh-ROO-bih-sin IH-myoo-noh-KON-juh-gayt)

 A substance being studied in the treatment of cancer. It combines a monoclonal antibody with the anticancer drug doxorubicin. Monoclonal antibodies are substances that are made in the laboratory and that can locate and bind to cancer cells. Doxorubicin is a type of anthracycline antitumor antibiotic. When it is combined with a monoclonal antibody, it forms a type of drug conjugate. Also called SGN-15.



Previous Definitions:catheter, cauterize, cavity, CBC, CBE
Next Definitions:CBT-1, CC-1088, CC-4047, CC-49, CC-5013

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov